Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 5
2004 14
2005 16
2006 15
2007 17
2008 24
2009 27
2010 38
2011 33
2012 34
2013 29
2014 23
2015 24
2016 31
2017 38
2018 29
2019 17
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

373 results
Results by year
Filters applied: . Clear all
Page 1
Cyclin-dependent kinase 9 as a potential specific molecular target in NK-cell leukemia/lymphoma.
Kinoshita S, Ishida T, Ito A, Narita T, Masaki A, Suzuki S, Yoshida T, Ri M, Kusumoto S, Komatsu H, Shimizu N, Inagaki H, Kuroda T, Scholz A, Ueda R, Sanda T, Iida S. Kinoshita S, et al. Haematologica. 2018 Dec;103(12):2059-2068. doi: 10.3324/haematol.2018.191395. Epub 2018 Aug 3. Haematologica. 2018. PMID: 30076184 Free PMC article.
Targeting CDK9 Reactivates Epigenetically Silenced Genes in Cancer.
Zhang H, Pandey S, Travers M, Sun H, Morton G, Madzo J, Chung W, Khowsathit J, Perez-Leal O, Barrero CA, Merali C, Okamoto Y, Sato T, Pan J, Garriga J, Bhanu NV, Simithy J, Patel B, Huang J, Raynal NJ, Garcia BA, Jacobson MA, Kadoch C, Merali S, Zhang Y, Childers W, Abou-Gharbia M, Karanicolas J, Baylin SB, Zahnow CA, Jelinek J, GraƱa X, Issa JJ. Zhang H, et al. Cell. 2018 Nov 15;175(5):1244-1258.e26. doi: 10.1016/j.cell.2018.09.051. Epub 2018 Oct 25. Cell. 2018. PMID: 30454645 Free PMC article.
Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphoma.
Narita T, Ishida T, Ito A, Masaki A, Kinoshita S, Suzuki S, Takino H, Yoshida T, Ri M, Kusumoto S, Komatsu H, Imada K, Tanaka Y, Takaori-Kondo A, Inagaki H, Scholz A, Lienau P, Kuroda T, Ueda R, Iida S. Narita T, et al. Blood. 2017 Aug 31;130(9):1114-1124. doi: 10.1182/blood-2016-09-741983. Epub 2017 Jun 23. Blood. 2017. PMID: 28646117
Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy.
Sonawane YA, Taylor MA, Napoleon JV, Rana S, Contreras JI, Natarajan A. Sonawane YA, et al. J Med Chem. 2016 Oct 13;59(19):8667-8684. doi: 10.1021/acs.jmedchem.6b00150. Epub 2016 Jun 3. J Med Chem. 2016. PMID: 27171036 Free PMC article.
Sirtuin 2-mediated deacetylation of cyclin-dependent kinase 9 promotes STAT1 signaling in type I interferon responses.
Kosciuczuk EM, Mehrotra S, Saleiro D, Kroczynska B, Majchrzak-Kita B, Lisowski P, Driehaus C, Rogalska A, Turner A, Lienhoop T, Gius D, Fish EN, Vassilopoulos A, Platanias LC. Kosciuczuk EM, et al. J Biol Chem. 2019 Jan 18;294(3):827-837. doi: 10.1074/jbc.RA118.005956. Epub 2018 Nov 28. J Biol Chem. 2019. PMID: 30487288 Free PMC article.
CDK9: a signaling hub for transcriptional control.
Bacon CW, D'Orso I. Bacon CW, et al. Transcription. 2019 Apr;10(2):57-75. doi: 10.1080/21541264.2018.1523668. Epub 2018 Oct 11. Transcription. 2019. PMID: 30227759 Free PMC article. Review.
CDK9: A key player in cancer and other diseases.
Franco LC, Morales F, Boffo S, Giordano A. Franco LC, et al. J Cell Biochem. 2018 Feb;119(2):1273-1284. doi: 10.1002/jcb.26293. Epub 2017 Oct 5. J Cell Biochem. 2018. PMID: 28722178 Review.
373 results
Jump to page
Feedback